Literature DB >> 31061845

Amelioration of Dystonic Opisthotonus in Pantothenate Kinase-Associated Neurodegeneration Syndrome with Absent "Eye-of-the-Tiger" Sign Following Bilateral Pallidal Deep Brain Stimulation.

Nor Amelia Mohd Fauzi1, Norlinah Mohamed Ibrahim2, Shahizon Azura Mohamed Mukari3, Thanabalan Jegan4, Zariah Abdul Aziz5.   

Abstract

Entities:  

Keywords:  absent eye‐of‐the‐tiger sign; atypical PKAN; axial dystonia; deep brain stimulation; dystonic opisthotonus; globus pallidus internus

Year:  2019        PMID： 31061845      PMCID： PMC6476599          DOI： 10.1002/mdc3.12748

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  7 in total

1.  Subthalamic deep brain stimulation in patients with primary dystonia: A ten-year follow-up study.

Authors:  Zhengdao Deng; Yixin Pan; Chencheng Zhang; Jing Zhang; Xian Qiu; Shikun Zhan; Dianyou Li; Bomin Sun
Journal:  Parkinsonism Relat Disord       Date:  2018-05-31       Impact factor: 4.891

2.  Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN).

Authors:  Rafael Fermin Delgado; Pedro Roa Sanchez; Herwin Speckter; Eddy Perez Then; Ramney Jimenez; Jairo Oviedo; Paulo R Dellani; Bernd Foerster; Peter Stoeter
Journal:  J Magn Reson Imaging       Date:  2011-11-29       Impact factor: 4.813

3.  Sustained quality-of-life improvements over 10 years after deep brain stimulation for dystonia.

Authors:  Elliot Hogg; Emmanuel During; Echo E Tan; Kishore Athreya; Jonathan Eskenazi; Jeffrey Wertheimer; Adam N Mamelak; Ron L Alterman; Michele Tagliati
Journal:  Mov Disord       Date:  2018-07       Impact factor: 10.338

4.  Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations.

Authors:  Valerio Leoni; Laura Strittmatter; Giovanna Zorzi; Federica Zibordi; Sabrina Dusi; Barbara Garavaglia; Paola Venco; Claudio Caccia; Amanda L Souza; Amy Deik; Clary B Clish; Marco Rimoldi; Emilio Ciusani; Enrico Bertini; Nardo Nardocci; Vamsi K Mootha; Valeria Tiranti
Journal:  Mol Genet Metab       Date:  2011-12-14       Impact factor: 4.797

5.  Pallidal stimulation improves pantothenate kinase-associated neurodegeneration.

Authors:  Pierre Castelnau; Laura Cif; Enza Maria Valente; Nathalie Vayssiere; Simone Hemm; Amandine Gannau; Annalisa Digiorgio; Philippe Coubes
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

6.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.

Authors:  Susan J Hayflick; Shawn K Westaway; Barbara Levinson; Bing Zhou; Monique A Johnson; Katherine H L Ching; Jane Gitschier
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

Review 7.  Dystonic opisthotonus: a "red flag" for neurodegeneration with brain iron accumulation syndromes?

Authors:  Maria Stamelou; Scarlett C Lai; Annu Aggarwal; Susanne A Schneider; Henry Houlden; Tu-Hsueh Yeh; Amit Batla; Chin-Song Lu; Mohit Bhatt; Kailash P Bhatia
Journal:  Mov Disord       Date:  2013-06-04       Impact factor: 10.338
  7 in total
  4 in total

Review 1.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

2.  Type 1 neurodegeneration with brain iron accumulation: a case report.

Authors:  Pedro Enrique Labrada-Aguilera; David Armando Guach-Hevia; Carlos Rafael Almira-Gómez; Daniel Alejandro González-Lago
Journal:  J Med Case Rep       Date:  2022-06-03

Review 3.  Effects of Deep Brain Stimulation on Postural Trunk Deformities: A Systematic Review.

Authors:  Karlo J Lizarraga; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2019-10-01

4.  Globus Pallidus Internus Deep Brain Stimulation for Dystonic Opisthotonus in Adult-Onset Dystonia: A Personalized Approach.

Authors:  Kantharuby Tambirajoo; Luciano Furlanetti; Michael Samuel; Keyoumars Ashkan
Journal:  Front Hum Neurosci       Date:  2021-06-10       Impact factor: 3.169
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.